SEEL
Seelos Therapeutics Inc (SEEL)
$1
Market is closedMarket is closed – opens on 8 PM, 06 Dec 2022
– opens on 8 PM, 06 Dec 2022
Key Stats
$0.9703
Day's Range
$1.06
$0.4803
52-Week Range
$1.87
| Returns | |
| 1 month return | 14.94% |
| 3 month return | 5.66% |
| 1 year return | 40.12% |
| 5 year return | 42.86% |
Company Information
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and other rare diseases. The Company's robust portfolio includes several late-stage clinical assets targeting indications including Acute Suicidal Ideation and Behavior (ASIB) in Major Depressive Disorder (MDD) or Post-Traumatic Stress Disorder (PTSD), amyotrophic lateral sclerosis (ALS), Sanfilippo syndrome, Parkinson's Disease, other psychiatric and movement disorders plus orphan diseases.
| Organization | Seelos Therapeutics Inc |
| Employees | 16 |
| CEO | Dr. Raj Mehra J.D., Ph.D. |
| Industry | Pharmaceuticals: Other |
Analyst Recommendation
based on 6 analysts ratings
Buy
100%
Buy
0%
Hold
0%
Sell
Based on 6 Wall street analysts offering stock ratings for Seelos Therapeutics Inc(by analysts ranked 0 to 5 stars)
Analyst Forecast
What analysts predicted
Upside of 480.0%Current
$1.0
Target
$5.8
Recommendation Trend
Based on 6 analyst
| Current | 1M Ago | 3M Ago | |
| Buy | 6 | 10 | 10 |
| Hold | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 |
| Consensus | BUY | BUY | BUY |
Highlights
| Market Capitalization | 115.7M |
| Book Value | $0.07 |
| Dividend Share | 0.0 |
| Dividend Yield | 0.0% |
| Earnings Per Share (EPS) | -0.61 |
| Wall Street Target Price | 5.8 |
Valuation
| Trailing PE | 0.0 |
| Forward PE | 0.0 |
| Price/Book (mrq) | 14.69 |
| Enterprise Value | 106.6M |
| Enterprise Value/Revenue | 549.68 |
| Enterprise Value/Ebitda | -1.3 |
Technicals
| Beta | 1.99 |
| 50 Day MA | 0.92 |
| 200 Day MA | 0.88 |
Institutional Holdings
Vanguard Group Inc
4.68%
Gendell Jeffrey L
4.58%
Uniplan Investment Counsel, Inc.
2.32%
Group One Trading, LP
2.17%
BlackRock Inc
1.66%
Mirae Asset Global Investments (Korea) Co Ltd
1.64%
Discover more
Frequently Asked Questions
What is Seelos Therapeutics Inc share price today?
Can Indians buy Seelos Therapeutics Inc shares?
How can I buy Seelos Therapeutics Inc shares from India?
Can Fractional shares of Seelos Therapeutics Inc be purchased?
What are the documents required to start investing in Seelos Therapeutics Inc stocks?
What are today’s High and Low prices of Seelos Therapeutics Inc?
What are today’s traded volumes of Seelos Therapeutics Inc?
What is today’s market capitalisation of Seelos Therapeutics Inc?
What is the 52 Week High and Low Range of Seelos Therapeutics Inc?
How much percentage Seelos Therapeutics Inc is down from its 52 Week High?
How much percentage Seelos Therapeutics Inc is up from its 52 Week low?
What are the historical returns of Seelos Therapeutics Inc?
Who is the Chief Executive Officer (CEO) of Seelos Therapeutics Inc?
Trading and brokerage services provided by
Banking and Remittance services provided by
Technology services provided by : Finzoomers Services Private Limited
Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*